Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia
M. Ferrer, N. Mourikis, E. E. Davidson, S. O. Kleeman, M. Zaccaria, J. Habel, R. Rubino, T. R. Flint, C. M. Connell, M. Lukey, E. P. White, A. P. Coll, A. R. Venkitaraman, T. Janowitz
Abstract
The dependency of cancer cells on glucose can be targeted with high-fat low- carbohydrate ketogenic diet (KD). However, hepatic ketogenesis is suppressed in IL-6 producing cancers, which prevents the utilization of this nutrient source as energy for the organism. In two IL-6 associated murine models of cancer cachexia we describe delayed tumor growth but accelerated onset of cancer cachexia and shortened survival when mice are fed KD. Mechanistically, we find this uncoupling is a consequence of the biochemical interaction of two simultaneously occurring NADPH-dependent pathways. Within the tumor, increased production of lipid peroxidation products (LPPs) and, consequently, saturation of the glutathione (GSH) system leads to ferroptotic death of cancer cells. Systemically, redox imbalance and NADPH depletion impairs the biosynthesis of corticosterone, the main regulator of metabolic stress, in the adrenal glands. Administration of dexamethasone, a potent glucocorticoid, improves food intake, normalizes glucose homeostasis and utilization of nutritional substrates, delays onset of cancer cachexia and extends survival of tumor-bearing mice fed KD, while preserving reduced tumor growth. Our study highlights that the outcome of systemic interventions cannot necessarily be extrapolated from the effect on the tumor alone, but that they have to be investigated for anti{-}cancer and host effects. These findings may be relevant to clinical research efforts that investigate nutritional interventions such as KD in patients with cancer. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=129 SRC="FIGDIR/small/528937v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@613bb6org.highwire.dtl.DTLVardef@19746a4org.highwire.dtl.DTLVardef@9ef652org.highwire.dtl.DTLVardef@3db934_HPS_FORMAT_FIGEXP M_FIG C_FIG HIGHLIGHTSO_LIKetogenic diet delays tumor growth but accelerates cancer cachexia and shortens survival C_LIO_LIIn the tumor, accumulation of lipid peroxidation products results in saturation of the GSH detoxifying pathway and ferroptotic death of cancer cells C_LIO_LIIn the host organism, systemic redox state imbalance causes NADPH depletion, GDF-15 elevations, and relative corticosterone deficiency C_LIO_LIDexamethasone coadministration with ketogenic diet delays onset of cancer cachexia by improving food intake, glucose homeostasis and utilization of nutritional substrates C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tumor Cytokine-Induced Hepatic Gluconeogenesis Contributes to Cancer Cachexia: Insights from Full Body Single Nuclei Sequencing
Ying Liu, Ezequiel Dantas, … Norbert Perrimon·bioRxiv·May 15, 2023
- A Ketogenic Diet Sensitizes Pancreatic Cancer to Inhibition of Glutamine Metabolism
Omid Hajihassani, Asael Roichman, … Jordan Michael Winter·Cell Reports MedicinePeer-reviewed·Apr 23, 2026
- Caloric restriction alters lipid metabolism to contribute to tumor growth inhibition
E. C. Lien, A. M. Westermark, … M. Vander Heiden·bioRxiv·Mar 9, 2020
- Decreased food intake contributes to elevated insulin-responsiveness in pre-clinical cancer cachexia
Emma Frank, Kaspar W. Persson, … Steffen Henning Raun·bioRxiv·Mar 15, 2026
- NAD+ limitation and α-ketoglutarate depletion define cancer induced muscle atrophy
Vassilis Papalazarou, Jack Coomes, … Karen H. Vousden·bioRxiv·Oct 16, 2026
- Sustained Glucose Turnover Flux Distinguishes Cancer Cachexia from Nutrient Limitation
Young‐Yon Kwon, Yanshan Liang, … Sheng Tony Hui·bioRxiv·May 15, 2025